Jingang Gui

1.3k total citations
63 papers, 948 citations indexed

About

Jingang Gui is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Jingang Gui has authored 63 papers receiving a total of 948 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Immunology, 15 papers in Molecular Biology and 13 papers in Oncology. Recurrent topics in Jingang Gui's work include Immune Cell Function and Interaction (17 papers), T-cell and B-cell Immunology (11 papers) and Immunotherapy and Immune Responses (8 papers). Jingang Gui is often cited by papers focused on Immune Cell Function and Interaction (17 papers), T-cell and B-cell Immunology (11 papers) and Immunotherapy and Immune Responses (8 papers). Jingang Gui collaborates with scholars based in China, United States and Singapore. Jingang Gui's co-authors include Dong‐Ming Su, Ruth W. Craig, Lisa Maria Mustachio, Peter F. Barnes, Xiaolin Wang, Cheng Li, Wenjun Mou, Xue‐Yi Zhu, Xike Zhu and Lili Cheng and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Jingang Gui

58 papers receiving 938 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jingang Gui China 16 405 284 144 99 90 63 948
Mitsuhiro Kanamori Japan 12 603 1.5× 290 1.0× 249 1.7× 68 0.7× 75 0.8× 15 1.2k
Maegan L. Capitano United States 19 298 0.7× 383 1.3× 183 1.3× 67 0.7× 48 0.5× 60 1.2k
Frederico S. Regateiro Portugal 14 428 1.1× 356 1.3× 270 1.9× 89 0.9× 62 0.7× 41 1.4k
Marianne Strazza United States 18 434 1.1× 397 1.4× 387 2.7× 104 1.1× 81 0.9× 39 1.3k
Jean Gabert France 18 316 0.8× 352 1.2× 207 1.4× 95 1.0× 88 1.0× 51 1.4k
Cornelia Cudrici United States 25 784 1.9× 610 2.1× 138 1.0× 111 1.1× 116 1.3× 54 1.7k
Thomas Carroll United States 15 346 0.9× 655 2.3× 107 0.7× 65 0.7× 80 0.9× 22 1.1k
John G. Gartner Canada 19 572 1.4× 262 0.9× 177 1.2× 114 1.2× 91 1.0× 52 1.5k
Robert Pick Germany 20 508 1.3× 383 1.3× 165 1.1× 88 0.9× 51 0.6× 30 1.1k
Peter Ng United States 10 340 0.8× 287 1.0× 107 0.7× 64 0.6× 48 0.5× 12 959

Countries citing papers authored by Jingang Gui

Since Specialization
Citations

This map shows the geographic impact of Jingang Gui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingang Gui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingang Gui more than expected).

Fields of papers citing papers by Jingang Gui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingang Gui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingang Gui. The network helps show where Jingang Gui may publish in the future.

Co-authorship network of co-authors of Jingang Gui

This figure shows the co-authorship network connecting the top 25 collaborators of Jingang Gui. A scholar is included among the top collaborators of Jingang Gui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingang Gui. Jingang Gui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Zhenping, Zhinan Lin, Peng Guo, et al.. (2025). Urine proteomics uncovers biomarker candidates for early identifying rituximab beneficiaries in paediatric steroid‐resistant immune thrombocytopenia. British Journal of Haematology. 207(4). 1323–1333.
2.
Gui, Jingang, et al.. (2025). Characterization of immune microenvironment associated with medulloblastoma metastasis based on explainable machine learning. Pediatric Investigation. 9(1). 59–69. 1 indexed citations
3.
Wang, Xiaolin, Jun Feng, Wei Wang, et al.. (2024). Intratumoral CXCR4hi neutrophils display ferroptotic and immunosuppressive signatures in hepatoblastoma. Frontiers in Immunology. 15. 1363454–1363454. 7 indexed citations
5.
Huang, Lijuan, et al.. (2023). Diversity of clinical phenotypes in a cohort of Han Chinese patients with PAX6 variants. Frontiers in Genetics. 14. 1011060–1011060. 1 indexed citations
6.
Wang, Xianwang, Wen-Qi Cai, Qiang Xin, et al.. (2023). Oncolytic virotherapy evolved into the fourth generation as tumor immunotherapy. Journal of Translational Medicine. 21(1). 500–500. 17 indexed citations
7.
Gu, Hao, Wenjun Mou, Zhenping Chen, et al.. (2023). Case report: Effectiveness of sirolimus in treating partial DiGeorge Syndrome with Autoimmune Lymphoproliferative Syndrome (ALPS)-like features. Frontiers in Pediatrics. 10. 1014249–1014249. 2 indexed citations
8.
Li, Ying, Xiaolin Wang, Han‐xue Yang, et al.. (2022). Profiles of Proinflammatory Cytokines and T Cells in Patients With Tourette Syndrome: A Meta-Analysis. Frontiers in Immunology. 13. 843247–843247. 13 indexed citations
9.
Xi, Yue, Wei Wang, Hua Wang, et al.. (2022). Impaired HPV-specific T-cell response in juvenile-onset recurrent respiratory papillomatosis patients. Clinical Immunology. 241. 109046–109046. 7 indexed citations
10.
Wang, Shengcai, Wei Wang, Jingang Gui, et al.. (2021). Correction to: A somatic mutation in PIK3CD unravels a novel candidate gene for lymphatic malformation. Orphanet Journal of Rare Diseases. 16(1). 321–321.
11.
Mou, Wenjun, Liwei Gao, Jianxin He, et al.. (2021). Compound heterozygous DCLRE1C mutations lead to clinically typical Severe Combined Immunodeficiency presenting with Graft Versus Host Disease. Immunogenetics. 73(6). 425–434. 4 indexed citations
12.
Felton, Jennifer M., David A. Dorward, Jennifer A. Cartwright, et al.. (2020). Mcl-1 protects eosinophils from apoptosis and exacerbates allergic airway inflammation. Thorax. 75(7). 600–605. 10 indexed citations
13.
Wang, Wei, Zhifei Xu, Jie Zhang, et al.. (2020). Tim-3 is a potential regulator that inhibits monocyte inflammation in response to intermittent hypoxia in children with obstructive sleep apnea syndrome. Clinical Immunology. 222. 108641–108641. 8 indexed citations
14.
Chen, Ling, Xiaolin Wang, Zhi Chen, et al.. (2019). Altered B-Lymphocyte Homeostasis in Idiopathic Nephrotic Syndrome. Frontiers in Pediatrics. 7. 377–377. 22 indexed citations
15.
Mou, Wenjun, Chang Su, Xi Chen, et al.. (2017). Increase in Peripheral Blood Intermediate Monocytes is Associated with the Development of Recent-Onset Type 1 Diabetes Mellitus in Children. International Journal of Biological Sciences. 13(2). 209–218. 31 indexed citations
16.
Mou, Wenjun, Wei Han, Xiaoli Ma, et al.. (2017). γδTFH cells promote B cell maturation and antibody production in neuroblastoma. BMC Immunology. 18(1). 36–36. 11 indexed citations
17.
Zhao, Jing, Guoliang Wang, Guixiang Wang, et al.. (2017). HLA-DRB1 and HLA-DQB1 alleles in Chinese Han patients with Juvenile-Onset recurrent respiratory papillomatosis. International Journal of Pediatric Otorhinolaryngology. 102. 119–122. 2 indexed citations
18.
Kim, Eui Ho, et al.. (2016). Mcl-1 regulates effector and memory CD8 T-cell differentiation during acute viral infection. Virology. 490. 75–82. 10 indexed citations
19.
Mou, Wenjun, Xi Chen, Hui Zhang, et al.. (2016). A novel deletion mutation in IL2RG gene results in X-linked severe combined immunodeficiency with an atypical phenotype. Immunogenetics. 69(1). 29–38. 8 indexed citations
20.
Choi, Young Il, Jonathan S. Duke‐Cohan, Wei Chen, et al.. (2013). Dynamic control of β1 integrin adhesion by the plexinD1-sema3E axis. Proceedings of the National Academy of Sciences. 111(1). 379–384. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026